April 27, 2011
Trials and Tribulations
Asia-Pacific IP Focus, 6th Edition, Managing Intellectual Property

In the last decade, both Thailand and Vietnam have experienced rapid growth in the pharmaceutical and biotech industries. This article examines the current issues facing research-based pharmaceutical companies in each country. In Thailand, pharmaceutical companies must deal with the government’s announcement of compulsory licenses on various key patented drugs, as well as the absence of a centralized procedure for approval of clinical trials and a multitude of data protection challenges. In Vietnam, the drug registration procedure is comparatively efficient, but multinational companies remain concerned about the availability of a reference mechanism for the approval of generic products.

Related Professionals
Nga Thi Phi Nguyen
+84 4 3772 5598
Siraprapha Claassen
+66 2056 5874